404: Page not Found
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
NIH Researchers Discover Otulipenia, a New Inflammatory Disease
Rare and sometimes lethal disease affects young children.
FDA Issues Recommendations to Reduce the Risk of Zika Virus Transmission
The new guidance is a part of the FDA’s ongoing efforts to protect HCT/Ps and blood products from Zika virus transmission.
Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.
One in Six People Worldwide Will Have a Stroke in Their Lifetime
A new survey commissioned by the American Heart Association/American Stroke Association found that many people who care for family or friends at high risk for stroke don’t know the potentially life-saving warning signs.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.